<p>Pfizer Inc and BioNTech have started the process for full approval of a booster dose of their <strong><a href="http://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates.html" target="_blank">Covid-19</a></strong> vaccine in people aged 16 years and older, the drugmakers said on Wednesday.</p>.<p>The companies intend to complete the submission by the end of this week. This could potentially pave the way for a third dose that can be offered to people with compromised immune systems.</p>.<p>US officials have said that Covid-19 vaccine booster shots will be made widely available to Americans starting September 20.</p>.<p>Earlier this week, US regulators granted full approval to the two-dose vaccine based on updated data from the companies' clinical trial and manufacturing review.</p>.<p>A third dose of the Pfizer-BioNTech vaccine is not currently authorized for broad use in the United States. However, under the amended Emergency Use Authorization, a third dose was authorised for administration to individuals at least 12 years of age who were immunocompromised.</p>.<p><strong>Check out DH's latest videos:</strong></p>
<p>Pfizer Inc and BioNTech have started the process for full approval of a booster dose of their <strong><a href="http://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates.html" target="_blank">Covid-19</a></strong> vaccine in people aged 16 years and older, the drugmakers said on Wednesday.</p>.<p>The companies intend to complete the submission by the end of this week. This could potentially pave the way for a third dose that can be offered to people with compromised immune systems.</p>.<p>US officials have said that Covid-19 vaccine booster shots will be made widely available to Americans starting September 20.</p>.<p>Earlier this week, US regulators granted full approval to the two-dose vaccine based on updated data from the companies' clinical trial and manufacturing review.</p>.<p>A third dose of the Pfizer-BioNTech vaccine is not currently authorized for broad use in the United States. However, under the amended Emergency Use Authorization, a third dose was authorised for administration to individuals at least 12 years of age who were immunocompromised.</p>.<p><strong>Check out DH's latest videos:</strong></p>